Record Q2 2026 results with Adjusted EBITDA up 10.2% and margin at 5.7%, driven by strong case volume growth and technology investments. Guidance for FY26 reiterates robust sales and earnings growth, with disciplined capital allocation and continued share repurchases.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.